Thanks for sharing the results of our IRONMET-HFpEF trial #AHA26 Mike! The full manuscript is available now, open access, at #Circulation. doi.org/10.1161/CIRCUL…
Dr. Gregory Lewis and Dr. C. Michael Gibson discuss the IRONMET-HFpEF trial: Single-dose ferric derisomaltose infusion improved the primary endpoint of peak oxygen uptake at 12 weeks in patients with HFpEF and iron deficiency, showing benefits of enhanced functional capacity.View quoted post on X
Watch video here: clinicaltrialresults.org/wp-content/upl…